Evidence map›Paper›PMID 31907174›Full record

ArticleHospital pediatrics2020

Oral Vitamin K Prophylaxis in Newborns: A Survey of Clinician Opinions and Practices.

Jessica H Cheng, Jaspreet Loyal, Kelly E Wood, Laura R Kair

Open access · greenAbstract read
In one paragraph

Article in Hospital pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Neonatologists and vitamin K hesitancy.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jessica H ChengDepartment of Pediatrics, University of California Davis, Sacramento, California; jhcheng@ucdavis.edu.
Jaspreet LoyalDepartment of Pediatrics, Yale School of Medicine, Yale University, New Haven, Connecticut; and.
Kelly E WoodStead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
Laura R KairDepartment of Pediatrics, University of California Davis, Sacramento, California.
University of California, Davis · USUniversity of Iowa · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Building Interdisciplinary Research Careers in Womens Health at UC Davis - Administrative SupplementK12HD051958 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI LANE, NANCY E · 2005 to 2023
$9.6M
NCATS NIH HHS UL1 TR001860NCATS NIH HHS UL1 TR001863NICHD NIH HHS K12 HD051958
6 · The paper itself

Abstract

objectivesThe majority of newborns in the United States receive intramuscular (IM) vitamin K for prophylaxis against vitamin K deficiency bleeding (VKDB). Oral vitamin K is less effective than IM vitamin K in preventing VKDB but is widely used in Europe and by some in the United States when parents refuse IM vitamin K for their newborn. Our aim was to assess the practices, opinions, and knowledge of newborn clinicians regarding oral vitamin K prophylaxis when parents refuse IM vitamin K.

methodsWe conducted an electronic survey of newborn clinicians from 3 academic medical centers in California, Iowa, and Connecticut. Descriptive statistics and χ

resultsOf 160 newborn clinicians at 3 sites, 110 (69%) completed the survey. Of respondents, 58 (53%) believed the incidence of IM vitamin K refusal is increasing and had prescribed or recommended oral vitamin K at least once. Regarding knowledge, 32 (28%) and 23 (20%) respondents did not know whether oral vitamin K decreases the risk of early- and late-onset VKDB, respectively. There were no significant differences in opinions, knowledge, or practices across institutions or practice settings (NICU, well-newborn nursery, or both) (

conclusionsOur study findings suggest that newborn clinicians may lack knowledge about the effectiveness of oral vitamin K in preventing VKDB. More information is needed about oral vitamin K regimens and outcomes of newborns who receive oral vitamin K.

Indexed as

Antifibrinolytic AgentsVitamin K Deficiency BleedingAcademic Medical CentersCaliforniaConnecticutFemaleHealth Knowledge, Attitudes, PracticeHumansInfant, NewbornIowaMaleNeonatologyParentsSurveys and QuestionnairesVitamin KAntifibrinolytic AgentsVitamin K

Identifiers

PMID31907174
PMCPMC6986901
OpenAlexW3004144138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.